Reuters logo
BRIEF-Celyad publishes additional pre-clinical data in support of THINK trial ‍​
June 21, 2017 / 8:07 AM / 3 months ago

BRIEF-Celyad publishes additional pre-clinical data in support of THINK trial ‍​

June 21 (Reuters) - CELYAD SA

* PUBLISHES ADDITIONAL PRE-CLINICAL DATA IN SUPPORT OF THINK TRIAL ‍​

* NEW DATA SHOW THE ABILITY OF CAR-T NKR-2 CELLS TO EFFECTIVELY CHALLENGE ESTABLISHED PANCREATIC CANCER XENOGRAFTS IN HUMANIZED MOUSE MODELS

* NEW RESULTS CONFIRM POTENCY OF CAR-T NKR-2 CELLS AGAINST VARIOUS HUMAN CANCER CELL LINES IN VITRO INCLUDING LEUKEMIA, COLORECTAL AND PANCREATIC CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below